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The enhanced permeability of lipid bilayer membranes at their gel-to-liquid phase transition has been explained using a ‘‘bilayer lipid
heterogeneity’’ model, postulating leaky interfacial regions between still solid and melting liquid phases. The addition of lysolipid to
dipalmitoylphosphatidylcholine bilayers dramatically enhances the amount of, and speed at which, encapsulated markers or drugs are released at
this, already leaky, phase transition through these interfacial regions. To characterize and attempt to determine the mechanism behind lysolipid-
generated permeability enhancement, dithionite permeability and doxorubicin release were measured for lysolipid and non-lysolipid, containing
membranes. Rapid release of contents from lysolipid-containing membranes appears to occur through lysolipid-stabilized pores rather than a
simple enhancement due to increased drug solubility in the bilayer. A dramatic enhancement in the permeability rate constant begins about two
degrees below the calorimetric peak of the thermal transition, and extends several degrees past it. The maximum permeability rate constant
coincides exactly with this calorimetric peak. Although some lysolipid desorption from liquid state membranes cannot be dismissed, dialyzation
above Tm and mass spectrometry analysis indicate lysolipid must, and can, remain in the membrane for the permeability enhancement, presumably
in lysolipid stabilized pores in the grain boundary regions of the partially melted solid phase.
D 2005 Elsevier B.V. All rights reserved.Keywords: Liposome; Drug delivery; Vesicle; Thermal-sensitive; Interface; Triggered1. Introduction
Over 30 years ago, Papahadjopoulos observed that ion
permeability through a lipid bilayer membrane showed an
anomalous peak as the membrane went through its gel-to-liquid
phase transition [1]. At this transition, gel and liquid phases
coexist, creating interfacial regions that consist of lipids with
large incompatibilities in molecular packing and hydrophobic
matching [2]. Since Papahadjopoulos’ first discovery, a number
of groups have developed models and theories, generally based
on two hypotheses, to explain the permeability phenomenon.
The first hypothesis, a more continuum approach, relates the
increase in permeability to the increase in lateral compressibility
of the membrane noted during the phase transition [3,4].
Measurements of the elastic area compressibility of dimyris-0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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transition region indicate that at the phase transition, the
membrane is highly compressible, approximately 5 times more
compressible than a completely melted liquid phase membrane
and approximately 40 times more compressible than the solid
state membrane [5]. Density fluctuations in the bilayer open up
cavities in the headgroup region that allow ions to enter and then
permeate through the bilayer [3]. The second hypothesis, a more
discrete approach at the microstructural level, relates the
permeability anomaly to the formation of leaky ‘‘interfacial
regions’’ that develop at micrograin boundaries, between gel and
liquid domains during the phase transition [2,6–8]. Combining
the two, we might hypothesize that the mirograin structure
necessitates and discrete model, but that compressibility could
indeed be extremely high at melting grain boundaries, allowing
for high density fluctuations particularly in these regions and
concomitant rearrangement, especially in the presence of a
second component.ta 1716 (2005) 77 – 96
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theories on this second hypothesis, and have proposed a ‘‘state
of bilayer heterogeneity,’’ describing the bilayer during the
transition as a dynamic system of coexisting liquid and solid
domains [2,8]. Initially, when the lipid membrane is cooled from
the liquid state (say during liposome processing) through its
main solidification transition, Tm, solid lipid starts to nucleate in
the melt. These nucleates continue to grow and form micro-
grains of solid lipid in the melt of the liquid membrane.
Eventually, as the transition nears completion and the last liquid
lipid is transformed, grain boundaries are created between the
solidifying domains, and the grains meet at different orientations
[8], much the same as occurs in most ‘‘traditional’’ 3-D poly-
crystalline materials [9]. This nucleation and growth of grains
creates a micrograin structure that resembles a soccer ball.
Althoughmaybe not as regular a pattern, it is made up of plaques
or relatively flat plates of solid lipid, that nevertheless, have to fit
on the lipid domain, i.e., a giant lipid vesicle, that can be tens of
microns in size or a small (100 nm diameter) spherical liposome.
This solid grain structure has been observed in fluorescence
microscopy images and freeze fracture electron micrographs of
DSPC monolayers on gas microparticles [10] and in transmis-
sion electron micrographs of 100 nm gel phase liposomes of the
same lipid and lysolipid composition as used in this study
containing the anti-cancer drug doxorubicin [11,12]. Crinkled
and faceted structures have also been observed using interfer-
ence contrast microscopy in giant lipid vesicles composed of
DMPC when the vesicles were cooled from the liquid phase and
solidified under zero tension in the Ph and Lh phases (Needham
and Evans, 1987, unpublished results).
When the solidified membrane is heated, melting initiates at
these grain boundaries [8], forming interfacial regions between
the still solid domains and melting liquid domains. These
interfacial regions are composed of lipid chains in intermediate,
excited conformational states, resulting in large incompatibili-
ties in molecular packing and hydrophobic matching, and a very
‘‘soft’’ interface [2,8,13]. As found for whole bilayers, com-
pressibility is proportional to permeability, and so it is the ‘‘soft’’
and ‘‘leaky’’ nature of these solid/liquid interfacial regions that
leads to the enhanced permeability to ions, drugs and other small
molecules that are initially trapped in the liposome interior while
the membrane is in its liquid phase, cooled quickly through the
transition, remain trapped, and then can leak from the liposome
into solute-depleted media as it starts to melt [13]. Most
importantly, at the mid point of the transition temperature, the
total mismatched area of these interfacial regions reaches a
maximum [13], and therefore the permeability also attains a
maximum.
This anomalous permeability at the phase transition is
enhanced by the inclusion in the bilayer of a second lipid or
lipid-like component. The addition of small amounts (10
mol%) of dicaprylPC (diC10) (critical micelle concentration
(CMC)=5 AM [14]) to dimyristoylPC (diC14) multilamellar
liposomes have also been studied experimentally and modeled
using Mouritsen’s bilayer heterogeneity model. Incorporation
of the shorter dichain lipid decreases the transition temperature
of the mixture, from ¨24.4 -C to ¨21–22 -C [15]. Bymeasuring the permeability of the dithionite ion (S2O4
2)
through multilamellar liposomes, Risbo et al. have determined
that the permeability rate at Tm is greater (although a quan-
titative rate is not provided) in membranes that contain 10
mol% diC10PC, versus pure diC14 vesicles [15]. Mouritsen’s
theory predicts that the shorter chain lipids partition at the grain
boundaries and further disturb molecular packing, thereby
increasing the fluctuations and heterogeneity when the inter-
faces melt which enhances the transition permeability [15].
Our laboratory has developed a thermal-sensitive liposome
(lysolipid-containing thermal-sensitive liposome (LTSL)) that
takes advantage of the anomalous permeability at Tm due to
the melting grain boundaries, resulting in a formulation that
releases trapped markers and drug contents at the phase
transition but much more quickly (tens of seconds) than in the
absence of lysolipid, and in the range clinically attainable by
mild hyperthermia (39–42 -C) [16,17]. By incorporating a
small amount (10 mol%) of the water-soluble lysolipids
(micromolar critical micelle concentration), monopalmitoyl-
phosphatidylcholine (MPPC) or monostearoylphosphatidylcho-
line (MSPC), into DPPC liposomes prior to cooling from the
liquid phase, the peak of the phase transition upon remelting is
shifted down slightly from ¨41.9 -C to 40.5 -C and 41.3 -C,
respectively. Differential scanning calorimetry (DSC) data
indicates that, although the addition of lysolipid decreases Tm
by more than 1 -C (for MPPC), the breadth of the transition
does not change (i.e., does not broaden), strongly suggesting
that the identical head group and well-matched acyl chain
compositions of MPPC and MSPC mix ideally in the DPPC
bilayer [17]. This is further supported by calorimetric and
nuclear magnetic resonance data from Van Echteld et al. of
mixtures of DPPC and MPPC that also demonstrates ideal
mixing of the two components in the solid phase. [18]. More
importantly, even though not as fast as at the midpoint of the
transition (i.e., at Tm), the onset of release of entrapped contents
(6-carboxufluorescein (6-CF)) occurs just above 39 -C, and the
MPPC containing LTSLs release over 80% of the 6-CF at 40–
41 -C in a few seconds, while pure DPPC liposomes release
minimal dye (20%) [17] even after 5 min incubation at their Tm.
Similar release results have been obtained for doxorubicin
(DOX)-loaded liposomes, and more recent data confirm and
extend these findings (Wright, et al, 2005, in preparation).
Using the doxorubicin-loaded LTSL formulation, murine
studies with a human tumor xenograft model in combination
with local hyperthermia (42 -C) showed unprecedented local
control (11 out of 11 complete regressions) [16].
Motivated by these preliminary in vitro and pre-clinical
studies, the experiments presented here were designed to test two
hypotheses regarding the mechanism behind the lysolipid-
generated permeability enhancement. The first hypothesis was
that whilst trapped in the solid phase in ideal solid solution, upon
heating to the transition and even passed it, lysolipid remains in
the bilayer and creates permeable defects and enhances drug,
aqueous contents marker, and H+ ion solubility in the bilayer due
to increased bilayer free volume. As the bilayer melts and the
interfacial regions liquefy, lysolipid already present in the
membranemay further enhance the permeability of these regions
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cussed by Risbo examining the effects of adding diC10 PC to
diC14 bilayer systems [15]. In addition, lysolipid may be unique
and provide actual porous defect structures since its natural self-
assembled structures are micelles with a curvature on the order
of the bilayer thickness and so its presence in the grain
boundaries may help stabilize defects in the membrane as head-
group lined pores. Furthermore, with one less acyl chain per
headgroup, (compared to the host di-chain phospholipid)
additional free volume could be introduced that may simply in-
crease solubility to the permeant species. The second hypothesis
is that, again, whilst trapped in the solid phase, the water-soluble
lysolipid (critical micelle concentration (CMC) of MPPC=4–7
AM [19,20], CMC of MSPC=4 AM [19]) may desorb from the
bilayer, entering the external media that is devoid of lysolipid,
leaving behind vacancy defects in the partially melted solid/
liquid interfacial regions through which small molecules could
pass. This ‘‘washout’’ of lysolipid has been noted in micropipette
experiments where single liquid phase giant vesicles (stearoy-
loleoylphosphatidylcholine (SOPC)) were bathed in a solution
of monooleoylPC (MOPC) [21,22]. After initial incorporation of
about 6 mol% of lysolipid in the membrane, while the membrane
remained intact, the lysolipid quickly dissolved out of the mem-
brane when bathed in a diluting medium [21,22]. It is important
to note though, that in these experiments the uptake was only
into the outer monolayer (transport by flip-flop of the lysolipid to
the inner bilayer leaflet takes much longer, by a factor of about
100, than the adsorption from and desorption into the aqueous
phase) and therefore desorption was from the outer monolayer
before significant amounts of lysolipid had been allowed to cross
the bilayer and partition into the inner monolayer. In the
liposome formulations tested here, the lysolipid is introduced
into the mixture from the beginning of lipid preparation and is
necessarily partitioned almost equally between the two halves of
the bilayer. Whether the lysolipid is therefore free to desorb fully
from both halves of the bilayer (as opposed to just the outer
monolayer) is of interest to test.
In order to distinguish between the two mechanisms listed
above, and to more comprehensively characterize the nature of
this enhanced membrane permeability, we have measured the
permeability rates of two unique molecules through lysolipid-
containing membranes, as well as other pure lipid bilayers,
under different conditions. To eliminate the apparently partial
contents release initially noted with 6-Carboxyfluorescein in
some of our previous work [17], the dithionite ion (S2O4
2) was
selected as a single, small molecule that does not form mole-
cular aggregates, and therefore its permeability should not be
limited by possible defect size selectivity. Measurements of the
release rate of DOX through the two lysolipid formulations and
pure DPPC membranes have also been made. The results from
this investigation indicate that lysolipid does not readily desorb
from the membrane upon heating to, and through the transition,
and supports the presence of lysolipid-stabilized pores in the
membranes, probably at melting grain boundaries, that faci-
litate the rapid release of contents from the lysolipid thermal-
sensitive liposome formulations upon heating to the phase
transition region.2. Materials and methods
2.1. Materials
Dipalmitoylphosphatidylcholine (DPPC, Tm=41.5–41.9 -C [23]), mono-
palmitoylphosphatidylcholine (MPPC), monostearoylphosphatidylcholine
(MSPC), palmitoyloleoylphosphatidylcholine (POPC, Tm=2 -C [23]) and
distearoyl-phosphatidylethanolamine-poly(ethylene glycol)-2000 (DSPE-PEG
(2000 molecular weight poly(ethylene glycol)) were purchased from Avanti
Polar Lipids, Inc., AL and used without further purification. N-(7-nitrobenz-
2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine,
triethylammonium salt (NBD-PE) was obtained from Molecular Probes, Inc.
Sodium Hydrosulfite (Na2S2O4), TRIZMA base, doxorubicin (DOX), citric
acid and Triton X-100 were obtained from Sigma Chemical Co. Sodium
chloride, and sucrose were purchased from Mallinckrodt, Inc. Sephadex G-
50 was obtained from Amersham Pharmacia Biotech.
2.2. Dithionite permeability: background and development of the
absorbance assay
Several groups have measured the permeability of anions and cations
through lipid vesicle bilayers. Most of the methods utilize ion-sensing
electrodes or radiolabeled ions that require very specialized equipment and
laboratory environments [1,24,25]. In this report, we measure the permeabil-
ity of the dithionite ion (S2O4
2, pKa’s=0.35, 2.45 [26]) through liposome
membranes using simple spectrophotometric absorbance measurements.
In aqueous solution, the dithionite ion is in equilibrium with the SO2

radical, a reaction intermediate in the nitro reduction of N-(7-nitro-2,1,3-
benzoxadiazol) (NBD) to its corresponding amine [27]. This reduction results
in the irreversible quenching of NBD fluorescence and virtually eliminates
the absorbance peak of NBD at 465 nm [28]. A number of groups have used
dithionite quenching of NBD fluorescence to measure lipid distribution
[29,30] and flip-flop [31]. Fluorescence quenching has also been used to
measure permeability through multilamellar vesicles [15,32] and single
bilayer vesicle membranes [33]. There are several concerns with the
fluorescence method, however, that can complicate permeability measure-
ments. First, continuous excitation of the fluorophore causes it to
photobleach, which can be mistaken for the NBD-dithionite quenching
reaction. Secondly, it is unclear whether or not self-quenching occurs
between the labeled lipids (expected at relatively high fluorescent lipid
concentrations which nevertheless can be in the few mol% range), especially
if and when they come in close proximity to each other at the bilayer
surface, as in grain boundaries (observations from this work). In addition to
these concerns, the use of multilamellar vesicles does not accurately model
the single bilayer, ¨100-nm diameter, extruded vesicles that are generally
used in clinical applications. In the experiments presented here, the
permeability was measured through extruded, unilamellar vesicles, using an
absorbance decay assay, which eliminated any photobleaching or self-
quenching concerns, and also allowed for the determination of accurate
temperature-dependent permeability rate constants on clinically relevant
samples.
Incorporation of 1 mol% of NBD head group labeled lipid into large,
unilamellar vesicles (LUV, ¨100 nm in diameter) results in a slightly
asymmetrically labeled bilayer [30], with a detectable 54% of the NBD
molecules residing on the outer monolayer and 46% residing on the inner
monolayer due to curvature restrictions (see results). The addition of
dithionite to the outside of the liposomes causes an immediate reaction with
the NBD molecules on the exterior monolayer (complete reaction within
about 10–20 s). Permeation of the S2O4
2 ion or SO2
 radical through the
bilayer results in a subsequent reaction with the inner monolayer at a rate of
¨0.25% labeled-lipid reacted/minute (i.e., permeation and reaction at this rate;
dioleoyl-PC vesicles at room temperature) [28]. Bilayer permeability is
therefore the rate limiting factor in the reaction. By monitoring the optical
absorbance at 465 nm, measurements of the temperature-dependent dithionite
permeability rate through DPPC and two LTSL bilayer membranes
(DPPC:MPPC and DPPC:MSPC) were made. Although permeability rate
constants are temperature and composition dependent, all membranes reached
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brium’’ temperature discrepancies that were previously noted in our
measurements of 6-CF release with similar lipid compositions [17].
Permeability through palmitoyloleoylphosphatidylcholine (POPC, Tm ¨2
-C) vesicles was also examined as a measure of the temperature-dependent
permeability of liquid state membranes throughout the temperature range
studied as a non-phase transition lipid control.
2.3. Liposome preparation for dithionite permeability measurements
Four liposome compositions based on DPPC were examined using the
dithionite permeability assay (all percentages indicate mol% of the minor
component(s)) DPPC:DSPE-PEG(4%), POPC:DSPE-PEG(4%); and LTSL
formulations DPPC:MPPC(10%):DSPE-PEG(4%) and DPPC:MSPC(10%):
DSPE-PEG(4%). Two sets of lipid samples were required for each
measurement. They were identical in composition, except that the ‘‘Blank’’
sample (used as a reference for the spectrophotometer) did not contain
labeled lipid, while the other sample, ‘‘NBD-labeled,’’ contained 1 mol%
NBD-PE. For each set, lipids were co-dissolved in chloroform and then dried
onto a round bottom flask using a rotovapor. Each film was hydrated with 1.5
ml of a solution (¨pH 7) of 100 mM NaCl with 709 mM sucrose (20 mg/ml
final lipid concentration). The salt provided ion screening, while the sucrose
was added to increase the solution osmolarity to ¨900 mOsm. This elevated
osmolarity ensured that when 30 mM dithionite ions were added, the increase
in external solution osmolarity relative to inside the liposomes was only ¨6%
and all but eliminated osmotic pressure across the membranes. (Note: because
the permeability measurement is due to dithionite crossing the bilayer from
outside to inside, this initial osmotic gradient is not responsible for the
observed permeability enhancement, as it may be if the permeant species was
trapped inside and moved out down an osmotic flow.) In the case of the
lysolipid temperature-sensitive formulations, the NaCl/Sucrose buffer for
hydration also contained 1 AM of the appropriate lysolipid (MPPC or
MSPC) to provide an equilibrating amount of lysolipid in solution during
self-assembly. The liposomes were then extruded using a Lipex Biomem-
branes Thermobarrel Extruder (Lipex Biomembranes, Vancouver, BC)
through two, 100 nm polycarbonate membrane filters (Poretics) so as to
yield a homogeneous sample of unilamellar lipid vesicles. For both
hydration and extrusion of liposomes, the temperature of the sample was
maintained above Tm at 45–48 -C with a circulating water bath to ensure that
the liposomes were liquid phase and the lipid composition was well mixed in the
bilayer.
Following extrusion, the liposomes were cycled five times through their
transition temperature, allowing the sample to equilibrate for 5 min above
(¨48 -C) and below (10 -C) Tm. This cycling ensured that vesicles that may
initially rupture due to the ¨25% reduction in bilayer area during the first
lipid-freezing cycle [34] can re-anneal into intact liposomes with minimal
tension in their membranes upon re-heating to the liquid phase and so reseal.
Finally, after cooling the liposomes to room temperature and their solid state,
(final cooling rate ¨40 -C/min), they were passed through a Sephadex G-50
column, pre-equilibrated with the NaCl/Sucrose buffer, to remove free
lysolipid.
2.4. Differential scanning calorimetry
In order to measure the calorimetric phase transition profiles, including the
transition temperatures of the various samples, all lipid components were first
co-dissolved in chloroform at the appropriate ratios. A lipid solution of each of
the four compositions (excluding POPC-no phase transition in the temperature
range of interest) was prepared at a concentration of approximately 20 mg of
total lipid per ml of chloroform. 250 Al (5 mg total lipid weight) of this
mixture was then dried on the bottom of a glass vial under a stream of
nitrogen and stored under vacuum overnight at room temperature. The next
day, the lipid film was scraped off the bottom of the vial and 1 mg of the film
scrapings was placed directly into the base of an aluminum Perkin-Elmer DSC
pan. 10 Al of DI water was then added to the lipid sample and the sample pan
was sealed using the aluminum top and a Perkin-Elmer Sample Pan Crimper
Press. The entire sample pan was then heated to 60 -C for 1 h to fully hydratethe sample. The samples were then thermally scanned from 30 to 50 -C at a
rate of 0.2 -C/min.
2.5. Absorbance measurements
After column filtration, both ‘‘blank’’ and ‘‘NBD-labeled’’ liposomes were
diluted in NaCl/Sucrose buffer to a final lipid concentration of 3 mM.
Absorbance measurements were made using a Shimadzu UV-1601 Spectro-
photometer. This instrument uses a dual cuvette system, where the ‘‘sample’’
cuvette (NBD-labeled sample) is always measured relative to a ‘‘reference’’
cuvette. Initially, both cuvettes were filled with 1 ml of ‘‘blank’’ liposomes that
did not contain NBD-labeled lipid. Both ‘‘sample’’ and ‘‘reference’’ cuvettes
were equilibrated to the proper recording temperature with the use of a
circulating water bath connected to the spectrophotometer’s water circulation
system. The ‘‘sample’’ cuvette was stirred using an InstechR stirring system
that fits on the top of the cuvette and uses a short stirring rod to agitate the
solution. The temperature was monitored with a small thermocouple wire
inserted into the cuvette. After 10 min of equilibration, the spectrophotometer
was ‘‘zeroed’’ at 465 nm, i.e., any absorbance at this wavelength was subtracted
from the ‘‘sample’’ reading (normally on the order of a few tenths of a percent).
The ‘‘sample’’ cuvette was washed and then filled with 1 ml of ‘‘NBD-labeled’’
liposome solution, while the ‘‘reference’’ cuvette and solution were left in the
instrument.
The ‘‘sample’’ was then equilibrated to the appropriate temperature for 10
min with constant stirring. After 10 min, absorbance readings at 465 nm were
started, with the instrument programmed to automatically record measurements
every 10 s. These readings were always within 1% of each other, yielding a
stable absorbance trace. After 2 min, 30 Al of 1 M Dithionite ions was added to
both cuvettes (30 mM total ions). 1 M Dithionite solution was prepared from
Sodium Hydrosulfite (Na2S2O4) in 1 M TRIZMA buffer. Addition of ions to
both cuvettes insured that any decrease in absorbance was due to dithionite–
NBD reaction and not simply to dilution of the ‘‘sample’’ volume. The stirring
mechanism was replaced and the absorbance of the ‘‘sample’’ was recorded for
a total of 30 min, with measurements automatically recorded every 10 s. After
30 min, 20 Al of 10% TRITON X-100 was added to both cuvettes. (TRITON
X-100 does not alter the absorbance signal at 465 nm.) After 5 min, to allow for
complete liposome lysis and exposure of all unreacted lipid, a final absorbance
reading was made. This reading corresponded to 100% reacted NBD molecules
(additional dithionite ions did not reduce this final value).
The addition of dithionite to the outside of the liposomes resulted in an
immediate reaction of the NBD molecules on the exterior monolayer (complete
reaction within about 10–20 s). Permeation of the S2O4
2 ion or SO2
 radical
through the bilayer resulted in a subsequent reaction with the inner monolayer
[28]. By monitoring the optical absorbance at 465 nm, measurements of the
temperature-dependent rate constant at which dithionite ions cross the bilayer
membranes were made.
2.6. Lysolipid enhancement mechanism
The experiments outlined below were designed to determine whether
lysolipid desorption from the bilayer was responsible for the permeability
enhancement, or if it was the presence of the single chain lipid, remaining in the
membrane and creating in situ defects, possibly at grain boundary regions, that
accounted for the increase in transmembrane transport over and above the
anomalous permeability at the phase transition of the pure lipid.
In the first experiment, dithionite permeability measurements were made
following dialysis of the liposomes to remove any desorbing lysolipid as
follows. Liposomes were prepared as outlined above. Following column
filtration, 1 ml of the NBD labeled sample was placed in a PierceR ‘‘Slide-A-
Lyzer’’ dialysis chamber (10,000 MW cutoff). This chamber was dialyzed at
45–48 -C against 400 ml of the NaCl/Sucrose buffer. At this elevated
temperature, the liposome membranes are in a completely liquid phase and
therefore should allow the water-soluble lysolipid every chance to desorb and
enter the external medium [21,35]. After dialysis for 24 h, the external buffer
was exchanged for another 400 ml of NaCl/Sucrose and the sample was
dialyzed for another 24 hrs at 45–48 -C. Initially, the lysolipid concentration in
the membrane was equivalent to ¨0.3 mM in the total solution volume. After
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reached equilibrium between the membrane and solution) would be ¨100 AM,
still above the critical micelle concentration (CMC) of MPPC of ¨4–7 AM
[19,20]. After the second dialysis cycle, however, the concentration, if all the
lysolipid desorbed, would be approximately 38 nM, well below the CMC and
therefore expected to be present only as single monomers in solution.
Following the second overnight incubation, the vesicles were removed from
the dialysis chamber, cooled to room temperature, and the dithionite
permeability experiments were performed as before.
Dithionite permeability measurements were also made using vesicles that
did not initially contain 10 mol% MPPC in the lipid film, but instead, the
lysolipid was added to the outside of preformed DPPC liposomes.
DPPC:DSPE-PEG(4%):NBD(1%) vesicles were hydrated and extruded as
above and allowed to equilibrate for 10 min in the spectrophotometer cuvette at
the appropriate temperature. The equivalent of 10 mol% MPPC was then added
to the external volume (bringing the solution to 0.3 mM MPPC) and allowed to
equilibrate with the vesicles for 10 min at the test temperature The dithionite-
absorbance decay assay was then carried out as before. These experiments were
used to determine whether MPPC initially outside the membranes caused the
same permeability enhancement as if it were incorporated during the hydration
process, i.e., its presence in the membrane was required for the enhancement.
Thin Layer Chromatography (TLC) and Proton Nuclear Magnetic
Resonance (NMR) analysis were performed to clarify whether lysolipid was
remaining in the membrane, or desorbing out of the liposomes, during the
dialysis procedure. For TLC analysis, the following three samples were
prepared: 30 mg of DPPC:DSPE-PEG(2000) (4%), 30 mg of DPPC:
MPPC(10%):DSPE-PEG(2000) (4%) and 2.03 mg (i.e. equivalent to 10
mol%) MPPC. Each sample was hydrated with 1 ml NaCl/Sucrose, extruded,
and then dialyzed for 48 h as described above. A phase separation procedure
was then used to remove the water from the samples. 100 Al of each sample
were placed in an Eppendorf tube and 375 Al of chloroform/methanol (1:2
volume ratio) was added to generate a monophase. The solutions were
vortexed, and 125 AL of chloroform was added, and the solutions vortexed
again. 125 Al of DI water was added, resulting in a phase separation. The
samples were then spun down in an Eppendorf tube, using a microcentrifuge at
9000 rpm for 1 min. This produced a two-phase sample, with an upper water
phase and a bottom organic layer containing the lipids. The top water layer was
removed and the bottom layer dried down under a stream of nitrogen and then
dried fully under vacuum overnight. 181 ml of chloroform was added to each
sample to completely solubilize the lipid for spotting.
10 Al (¨150 nmol of lipid) of each of these solutions were spotted on a
silica TLC plate using a Hamilton Syringe. The plate was then placed in a glass
development chamber containing ¨200 ml of the solvent mixture chloroform/
methanol/DI H2O (65:25:4, volume ratios). The top of the chamber was sealed
with vacuum grease and the plate was run for approximately 1 h, or until the
solvent reached a few centimeters from the top of the TLC plate. The plate was
removed from the chamber and allowed to dry completely before developing
with iodine crystals.
Proton Nuclear Magnetic Resonance Spectroscopy (NMR) measurements
were performed as follows. A 100 mg sample of DPPC:MPPC(10%):DSPE-
PEG(2000) (4%) (no NBD) was prepared as above, but here, 2 ml D2O was
used to hydrate the sample rather than NaCl/Sucrose buffer. Following
extrusion, 1 ml of this sample was placed in a slide-a-lyzer set-up and dialyzed
for 48 h at 45–48 -C against 50 ml of D2O. Following the incubation, the
dialyzed sample and a sample of the dialysate (external D2O) were removed for
analysis. Two control samples were also analyzed; a non-dialyzed
DPPC:MPPC(10%):DSPE-PEG(2000) (4%) sample and a control sample of
MPPC in D2O. This control MPPC sample was 0.27 mM, a concentration
equivalent to MPPC in the external dialysate assuming that all of the MPPC
desorbed out of the vesicles. The MPPC control and dialysate sample were
analyzed at room temperature. Both of the DPPC:MPPC(10%):PEG(4%)
samples were analyzed at 50 -C (above Tm) to enhance the rotation and proton
signals from the lipids.
2.7. Micropipette manipulation
Just as had been done for DMPC and SOPC/POPE vesicles previously
[34,36] we carried out micropipette studies to observe, for giant lipid vesicles(¨30 Am diameter), the lipid vesicle membrane area changes (equivalent to the
cumulated DPPC area per molecule changes) that accompany the phase
transition in the LTSL formulation, and to check to see if the vesicles stayed
intact as they were taken through the gel/liquid phase transition temperature
during a heating scan and cooling scan. Vesicles for micromanipulation were
prepared by hydrating ¨1 mg of DPPC:MPPC(10%):DSPE-PEG(4%) lipid
dried onto a Telfon disk with 15 ml of 200 mM sucrose [37]. The vesicles were
then incubated for 3 h at 45 -C. They were then diluted ¨5 Al:1000 Al in 200
mM glucose and placed into a temperature-controlled micromanipulation
chamber containing 200 mM glucose [38,39]. Single, giant unilamellar vesicles
were selected from the bottom of the chamber and held in a ¨10 um diameter
micropipette with a very low suction pressure (20–30 dyn/cm2) just to keep the
vesicles from floating away from the pipette [34,40]. The vesicles were then
cycled five times through their transition temperature of 40.5 -C (starting at¨35
and ending at ¨42 -C, holding for several minutes at each end temperature).
2.8. Doxorubicin loading
Doxorubicin (DOX) was loaded into the liposomes using the pH gradient
loading method described initially by Mayer et al. [41] and later by Madden et
al. [42] with slight modifications (loading times and incubation temperatures).
Thirty mg lipid films (DPPC:DSPE-PEG(4%), DPPC:MPPC(10%):DSPE-
PEG(4%) and DPPC:MSPC(10%):DSPE-PEG(4%)) were hydrated with 3 ml
(10 mg/ml lipid) of 300 mM pH 4. 0 Citric Acid buffer containing 1 AM of the
appropriate lysolipid for the LTSL formulations. The liposomes were then
extruded through two 100-nm filters. This lipid suspension was cooled to room
temperature and maintained below its transition temperature until drug loading.
In order to establish the pH gradient as described in Madden et al. [42], the
liposomes were passed through two consecutive, different Sephadex G-50 mini
size exclusion columns. Rather than using DI water to hydrate the gel beads for
the columns, 20 mM HEPES (Sigma) buffer at pH 7.4 was used so that the
external pH 4.0 citrate buffer was exchanged for the pH 7.4 HEPES buffer in
the beads, while maintaining the pH 4.0 liposome interior. Doxorubicin was
prepared at 5 mg/ml in saline (0.8 g NaCl/100 ml in DI water) and added to the
liposome suspension at a 10:0.5, lipid/drug, weight ratio. The liposomes and
DOX were then incubated together.
For the pure DPPC liposomes, >95% drug loading was achieved
reproducibly by incubating at 60 -C for 10 min [43]. If the LTSL formulations
are heated above Tm to maximize drug loading, within a few minutes at Tm, the
pH gradient was lost (Ickenstein and Anyarambhatla unpublished results).
Because of the enhanced transition permeability, the citrate buffer also appears
to leak out of the liposome interior as doxorubicin is noted to gel in the external
solution if the temperature is raised to the transition region, not having
necessarily gone above Tm, with DOX present in the external medium. This
implies that the pH gradient can readily dissipate because of the acute
permeability of this temperature-sensitive formulation, and as we will show in
the data, this can occur on the lower shoulder of the calorimetry profile, 1–2
degrees below the mid point of the transition signified by Tm. Therefore, a
method of loading the drug below its transition temperature was developed.
The pH gradient is established in the same manner as above, but incubation
with drug was carried out at room temperature (23–25 -C) overnight (20–24
hrs) for the DPPC:MPPC (10%) formulation, and at 37 -C for 20 min for the
DPPC:MSPC (10%) formulation. Even though the membranes are in a gel
phase, the presence of the lysolipid increases the permeation, maybe by
increasing solubility of DOX through the membrane, so that drug is able to
cross into the interior of the liposome (see Results for a more complete
description). By maintaining the temperature well below the threshold for
substantial hydrogen ion permeability, and loading at a drug to lipid ratio of
0.5:1 (w/w) (approximately 0.4:1 mol/mol), greater than 98% drug loading was
achieved.
To determine the amount of drug loaded, a simple fluorescence assay was
used based upon Doxorubicin’s self-quenching properties [44]. This charac-
teristic can be used to measure both release of drug, as well as percent loading.
Following the drug incubation step, the vesicles were cooled to room
temperature and then passed through a Sephadex G-50 (prepared in HEPES)
mini-column to remove any unencapsulated drug. To measure the encapsulation
efficiency, 5 Al of liposome-loaded solution (pre-column) was added to 1 ml
HEPES buffer along with 5 Al of 10% TX-100 to lyse the vesicles and release
Fig. 1. Dithionite permeability through DPPC:DSPE-PEG(2000) (4%) mem
branes. Relative Absorbance at 465 nm vs. Time (min) is shown for five
temperatures in the examined range. Data points and error bars represent the
mean and standard deviation respectively of three separate experiments.
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wavelength of 470 nm and an emission wavelength of 555 nm. A second 5-
Al sample (post-column) was then measured in the same manner. Percent
encapsulation was determined as follows:
Percent Encapsulation¼FLTXð post columnÞ=FLTXð pre columnÞT100 ð1Þ
2.9. Doxorubicin release measurements
The most ideal method to measure the temperature-dependent drug release
from a liposome sample would be to monitor a single sample heated to the
temperature of interest over a set time interval. Unfortunately, in the case of
DOX release from liposomes, this was not possible. In general, Doxorubicin is
an excellent choice for initial drug encapsulation and release measurements due
to its well-established loading methods and the fluorescence-dequenching assay
described above. However, constant excitation of the drug causes substantial
photobleaching, and therefore it was not possible to expose the same sample to
several fluorescence measurements in order to obtain time-dependent drug
release data. To alleviate this concern, we worked with individual samples for
each temperature and time, and the following method was used.
Small (1275 mm) glass test tubes (35 total tubes) were filled with 1 ml of
HEPES, pH 7.4 buffer at room temperature (same buffer as was used during the
drug loading procedure). To each test tube, 5 Al of DOX-loaded liposomes was
added and mixed gently by swirling. All of the test tubes were placed into a test
tube rack, and the entire rack was submerged into a circulating water bath
equilibrated to the temperature of interest so that the solution in the tubes was
completely submerged below the level of the water, but the tops of the tubes
were not in contact with the water.
For the first 5 min, starting at time zero, one test tube was removed every 20
s. Immediately upon removal, the test tubes were placed into an ice water bath
to quickly cool them below Tm (less than 1 s) and stop any subsequent drug
release. Drug release at the experimental temperature was monitored over 30
min with a single tube removed every 60 s (5–18 min) and then every 120 s
(20–30 min). In this manner, every test tube gave a single time point, all the
way up to the last 30-min time point. When the last test tube was removed, each
sample was read separately by placing the tube’s entire 1 ml into a quartz
cuvette and recording the fluorescence as above (Flt). Six random samples were
then chosen, lysed with 5 Al of 10% TX-100 and a final fluorescence recording
was made. These six readings were then averaged for a final ‘‘100% Released’’
value (FlTX). Percent of drug release was then calculated, where, Flt0 was the
fluorescence of the zero time point sample.
Percent Release¼½ðFltFlt0Þ=ðFlTXFlt0ÞT100 ð2Þ
Percent release from Eq. (2) was converted into moles of drug released as
follows. 100 nm liposomes have an entrapped volume of approximately 1 Al/
Amol of lipid [45]. Based upon the initial amount of lipid, and assuming that
each liposome was unilamellar, the total encapsulating volume was estimated.
Since the amount of drug added to the liposomes, and the loading efficiency
were both known, it was straightforward then to calculate the amount of drug,
in moles, encapsulated and then released. For the procedure described above
using 20 mg of lipid and 1 mg of drug loaded at 98% efficiency:
Total volume of liposomes loaded=27.2 Al;
Concentration of drug loaded=62.4 mM;
Total number of moles in 5 Al aliquot=3.86 nmol.
3. Results
3.1. Dithionite permeability
The dithionite permeability experiment gave a measure of
the amount of dithionite that crossed the membranes of the
liposomes in the sample as a function of temperature, since
dithionite rapidly quenches the NBD fluorescence and absor-bance (measured at 465 nm) of the labeled liposomes on the
outside monolayer, and on the inside if the membranes are
permeable. To allow for comparisons between the various
compositions, readings from the absorbance spectrophotometer
were converted to relative absorbance values as follows. Prior to
the addition of dithionite, the initial 2 min of steady state
absorbance readings for the unreacted liposome sample were
averaged (twelve total readings), resulting in a value that
corresponded to ‘‘100% unreacted NBD’’ (AbsInit). The addition
of dithionite caused the absorbance to quickly drop (within 20 s)
as all of the NBD molecules on the outside monolayers of the
liposomes reacted (as an example, see Fig. 1, sample at 30 -C).
Any subsequent decay of the absorbance signal (AbsDith) was
due to permeation of the dithionite ion through the lipid mem-
brane and reaction with NBD molecules on the inner mono-
layer. After 30 min, the addition of TX-100 destroyed all of the
vesicles, allowing dithionite to react with all NBD molecules,
and a final reading was made (AbsTX). This value was never
zero due to some residual absorbance signal, but was only ever a
few percent of the initial absorbance. Data collected after the
addition of dithionite was corrected by subtracting this residual
‘‘100% reacted’’ value. Dividing all of the data by the 100%
unreacted NBD (ABSinit) value gave relative absorbance
readings as follows:
Relative Absorbance ¼ AbsDith  AbsTX
AbsInit
ð3Þ
It is important to note that the absorbance decay noted in Figs. 1
and 2 is not simply a time-dependent dithionite-NBD reaction.
The reaction between free NBD-labeled lipids and dithionite
ions occurs within¨10–20 s in the stirred sample, regardless of
the temperature examined (as measured here and also noted in
[29]). In addition, the number of dithionite ions added to the
cuvette outnumbers the NDB molecules by 1000:1, ensuring
that the reaction does not significantly deplete the pool of ions.
Dithionite permeability through the DPPC:DSPE-PEG(4%)
membranes is represented in Fig. 1 as a plot of Relative
Absorbance at 465 nm versus Time in minutes for five
temperatures in the examined range (30 -C–48 -C). Data
points and error bars represent the mean and standard deviation-
Fig. 2. Dithionite permeability through DPPC:MPPC(10%):DSPE-PEG(2000)
(4%) membranes. Relative Absorbance at 465 nm vs. Time (min) is shown for
five temperatures in the examined range. Data points and error bars represent
the mean and standard deviation, respectively, of three separate experiments.
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fourth data point is shown to help with symbol identification.
For the first 2 min of the unreacted sample, the relative
absorbance remains steady at ‘‘1’’ for all traces. Following the
addition of dithionite at 2 min, the relative absorbance quickly
drops to ¨0.46 (the 130-s time point is not shown for all traces
as it often took just slightly longer than 10 s to add the
dithionite ion to both cuvettes). This value of 0.46 corresponds
to 46% remaining NBD molecules that have not reacted on the
inner monolayer of the liposomes in the sample. Any
subsequent loss of the absorbance signal is due to dithionite
ions crossing the bilayer and reacting with the NBD lipids on
the inner monolayer. Vesicle diameter was measured to be
125T13 nm by Photon Correlation Spectroscopy using a
Coulter N4 Plus Submicron Particle Sizer. The small curvature
of a 125-nm diameter vesicle (with its 4 nm thick membrane)
makes the surface area of the outer monolayer slightly larger by
a ratio of 54:46. The NBD lipids partition evenly, but since
there are overall less lipids in the inner monolayer than the
outer, the total absorbance changes reflect these relative inside
to outside absolute numbers of lipids at ¨54%:46% outer/
inner. The ability to detect these ratios confirmed the technique
as being an accurate representation of the lipid amounts in the
outer and inner membrane compared with previous fluorescent
lipid concentration measurements, which in turn then reflects
permeability as the lipid absorbance is altered by dithionite
transport.
Thus, in Fig. 1 at 30 -C, there is no measurable dithionite
ion permeability through the DPPC membranes, as the
absorbance readings remain stable at 0.46 over the 30-min
time course. At the higher temperature of 37 -C (for a new
sample), a slow decay in the absorbance trace with time is
noted (¨4% over 30 min), indicating that ions are slowly
permeating through the membrane. The absorbance curve at 40
-C shows even faster absorbance decay and permeability, while
at 42 -C (the transition temperature of DPPC, as determined
from DSC measurements) the absorbance drops fairly quickly
with time. The absorbance trace at 43 -C shows a slightly
slower rate of decay indicating a peak in permeability around
42 -C. In all cases, where permeability is noted, if the
experiment is followed for longer times (hours to days), thecurves will effectively reach 0 (less than 0.009) relative
absorbance demonstrating complete access by dithionite to
the interior-liposome lipids.
Fig. 2 shows a similar plot of relative absorbance at 465 nm
versus time for the DPPC:MPPC(10%):DSPE-PEG(4%) mem-
branes, but this time the decay in absorbance is much more rapid
at Tm. At 30 -C, the absorbance remains steady at 0.42. Although
a minor effect, it appears that the addition of 10 mol% MPPC
creates a slight preferential distribution of NBD lipid to the outer
monolayer from the expected 54% to 58% and concomitantly
reduces the amount of lipid in the inner monolayer from 46% to
42%. Liposome diameters were comparable DPPC controls. As
with DPPC, the permeability of the DPPC:MPPC(10%)
membranes increases only slightly when the temperature is
raised to 37 -C. As the temperature is raised to 40 -C, very near
to the transition temperature for DPPC:MPPC(10%) (¨40.5 -C
from DSC measurements, i.e., slightly lower than for pure
DPPC), the permeability increases dramatically, as the absor-
bance drops to less than 40% remaining NBD absorbance within
in the first 60 s following the addition of dithionite, to only 5%
remaining within 6 min, and falling to ¨1% remaining by 15
min. Increasing the temperature for DPPC:MPPC(10%), traces
at 42 and 43 -C show slower absorbance decay than at Tm, but
faster than DPPC at the same temperatures, illustrating, again, a
permeability maximum at Tm.
In order to obtain a quantitative measure of the ion
permeability, Fig. 3 shows the method used to determine the
temperature-dependent ion permeability rates. Data and fits are
shown for three DPPC traces as an example. All compositions
and temperatures were analyzed in the same manner. Only data
collected after the addition of dithionite (>2 min, i.e., after the
outer monolayer reacted) was fit to determine the permeability
rate constants. The following equation was fitted to the data
using the Curve Fit feature of KaleidaGraphR.
Relative Absorbance ¼ m1Texp m2T tð Þ½  ð4Þ
Here, m1 and m2 are constants, and t is time in minutes. m1 is
the intercept of the best fit line with the time axis, and therefore
represents the amount of relative absorbance remaining after
the outside monolayer has been reacted, i.e. ¨0.46 (or 0.42 as
in the case of the Lysolipid-containing samples). The constant,
m2, represents the rate constant of the absorbance decay. In all
cases, the correlation coefficient (R) was greater than 0.95
where exponential decay was noted (i.e. greater than 30 -C). In
the example in Fig. 3 for DPPC, the values for m1 are all fairly
close to the expected 0.46, and m2 increases from ¨0.0012 at
30 -C to ¨0.019 at 40 -C, to ¨0.058 at 42 -C. The same curve
fitting was performed on all the absorbance data for all
membranes studied, and in all cases, the correlation between
the curve fit and data for all temperatures greater than 30 -C
was greater than 0.95 showing that the dithionite ion transport
across the membrane, and its binding to the inner NBD lipids,
was an exponential process. Given that binding is not the rate
determining step [29], it is bilayer transport that is being
measured and is an exponential.
Fig. 4 is a compilation plot of the permeability rate constants
(m2, in units of 1/min) for pure DPPC:DSPE-PEG(2000)
Fig. 3. Method used to determine dithionite ion permeability rate constants. DPPC:DSPE-PEG (2000) (4%) relative absorbance data vs. time collected after the
addition of dithionite (i.e., 2 min and outer monolayer reacted) were fit using an exponential: y =m1exp(m2 t). Here, m1 represents the intercept and m2 (1/
min) the temperature-dependent rate constant. In all cases where absorbance decay was observed, correlation was greater than 0.95.
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DSPE-PEG(2000) (4%) and DPPC:MSPC(10%):DSPE-
PEG(2000) (4%) through the temperature range, 30–52 -C.
The lines joining the data are shown simply to aid the eye. The
permeability rate constants for DPPC from 30–37 -C are very
slow, less than 0.0013/min, and then begin to increase near 39 -C
and reach a local maximum of 0.058/min at ¨42 -C (Tm). The
rate constants then drop below this local maximum when the
temperature is increased to 42.5 -C, remain lower through ¨44
-C, and then increase above the anomalous permeability peak at
Tm, if the temperature is raised above 45 -C.
Permeability rate constants for POPC shown in Fig. 4
represent dithionite ion permeation through an intact bilayer
membrane that is in its liquid crystalline phase over the entire
temperature range. A steady increase in dithionite permeability
rate constants occur with increasing temperature, but no localFig. 4. Compilation of dithionite ion permeability rate constants (1/min). Rate
constants are shown for DPPC:DSPE-PEG(2000) (4%), DPPC:MPPC(10%):
DSPE-PEG(2000) (4%), DPPC:MSPC(10%):DSPE-PEG(2000) (4%), and
POPC:DSPE-PEG(2000) (4%) through the temperature range studied. Lines
connecting the data are presented simply to aid the eye.maximum is noted, because there is no phase transition over
the temperature range. It is interesting to note that the DPPC
curve becomes coincident with the liquid phase POPC curve at
temperatures above Tm, i.e., when both membranes are in their
liquid phase, and that the anomalous peak in permeability at the
DPPC transition is only slightly higher than this liquid phase
lipid at the same temperature.
The permeability rate constants for DPPC:MPPC(10%) in
Fig. 4 indicate minimal gel phase permeability below 37 -C,
virtually identical to DPPC over the same temperatures. For
this LTSL, however, permeability rate constants begin to
increase at ¨38–39 -C and reach a peak (0.372/min) at the
membrane phase transition temperature, ¨40.5 -C (each
temperature is a separate sample). At the slightly higher
temperature of 41 -C (also separate sample), the rate constants
drop below this peak and then continue to increase slightly as
temperatures higher than this are measured (using subsequent
separate samples). It should also be noted that the liquid phase
permeability rate constants for the LTSL are substantially
higher than those of liquid phase DPPC or liquid phase POPC
(see Discussion).
Rate constants for DPPC:MSPC(10%) formulation shown
in Fig. 4 also indicate minimal gel phase permeability through
39 -C, virtually identical to DPPC. At higher temperatures
(again, each temperature is a separate sample), substantial rate
enhancement is noted, reaching a peak at 41.3 -C (Tm), the rate
constants being just slightly lower than at the Tm peak for the
DPPC:MPPC composition. At higher temperatures above Tm,
the rate constants through the liquid phase membrane drop
below this maximum, but remain above the pure DPPC and
POPC, and just slightly lower than the MPPC formulation.
Note though, that all the liquid phase permeability rate con-
stants appear to be approaching common values at temper-
atures in the range of 50 -C and above.
To start to explore the permeability mechanism and how it
relates to melting of the solid lipid bilayer microstructure, a
plot of ion permeability rate constants for DPPC:MPPC(10%)
Fig. 5. Calorimetric data and permeability rate constants. Calorimetric data (endothermic heat flow in mWatts—solid line) and dithionite ion permeability rate
constants (1/min—solid circles and dashed line) for DPPC:MPPC(10%):DSPE-PEG(2000) (4%) membranes and DPPC:MSPC(10%):DSPE-PEG(2000) (4%)
membranes (inset) are shown as a function of temperature.
Fig. 6. Ion permeability rate constants following dialysis. Plot of dithionite
ion permeability rate constants (1/min) versus temperature for
DPPC:DSPE-PEG(2000) (4%), DPPC:MPPC(10%):DSPE-PEG(2000) (4%)
and DPPC:MPPC(10%):DSPE-PEG(2000) (4%) following 48 h of dialysis
at 45–48 -C.
J.K. Mills, D. Needham / Biochimica et Biophysica Acta 1716 (2005) 77–96 85plotted together with DSC heat flow data is shown in Fig. 5.
Note that the permeability begins to increase dramatically just
above 38 -C and is already almost a maximum at 39 -C, yet the
heat flow only starts to become significant (proportional to
mass of lipid melted) near 39.5–40 -C. The permeability rate
constant peak coincides with the thermal Tm at 40.5 -C. A
similar plot for the DPPC:MSPC(10%) composition is shown
in the inset of Fig. 5. Liposome membrane permeability starts
to increase at just above 39 -C, with significant melting starting
at ¨40.5 -C. Again, it is important to note that the peak in
permeability rate constant coincides with the transition
midpoint at 41.3 -C.
The results from the experiments designed to determine
whether the enhancement mechanism was related to lysolipid
desorbing from the membranes or the presence of defect-
stabilizing lysolipid remaining in the membranes are presented
in the following figures. In Fig. 6, dithionite ion permeability
rate constants are shown for pure DPPC, the DPPC:MPPC(10%)
formulation as made, and a separate DPPC:MPPC(10%)
formulation after being dialyzed for 48 h at 45–48 -C. It is
important to note from this figure that following the elevated
temperature dialysis, ion permeability rate constants are nearly
identical to the non-dialyzed samples in both the gel (30–38 -C)
and liquid phase regions (42–48 -C). In addition, the initial drop
in relative absorbance during the dithionite permeability
experiment (outer monolayer reaction) was still to ¨0.42 of
the original unquenched value. These results indicate the
presence of stable bilayer vesicles below and above the tran-
sition temperature. Importantly, they also suggest that lysolipid
is still present in the membranes since the temperature of the
peak values is the same and the ion permeability rate constants
are a little lower but still similar to undialyzed samples, and the
enhancement in the liquid phase is still noted. If the lysolipid had
desorbed, the permeability should have dropped back down to
the level of DPPC over the whole temperature range. Although
the rate constant near Tm at 40 -C appears to be slightly slowerthan for the undialyzed sample, (¨1.4 times slower), the
relative absorbance data are actually quite comparable, and
subtle differences are simply enhanced with the exponential
curve fit.
The results of the experiments of adding MPPC (equivalent
to 3 mM in solution) to the outside of preformed DPPC
indicated that the permeability rate constants throughout the
temperature range are nearly identical to the results from the
formulation with lysolipid present during the liposome
formation process and equilibrated with 1 micromolar lysolipid
during this processing (data not shown). This indicates that
lysolipid can exchange into the membrane and provide defect
permeability in the transition region and liquid phase mem-
Fig. 7. Arrhenius plot of dithionite ion permeability rate constants through
DPPC:DSPE-PEG(2000) (4%), POPC:DSPE-PEG(2000) (4%), DPPC:MPPC
(10%:DSPE-PEG(2000) (4%), and DPPC:MSPC(10%):DSPE-PEG(2000) (4%
vesicles. The ln of the permeability rate constants are plotted against 1
Temperature (degrees Kelvin)1000. Solid lines on the plot illustrate the
portions of the graph that were linearly fit to calculate the activation energy.
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presence of lysolipid in the membrane is necessary for the
permeability enhancement. Experiments were also performed
with lysolipid both in the membranes, and added to the external
volume (as 0.3 mM micelles). Virtually identical rates were
measured at all temperatures, further supporting the conclusion
that the presence, rather than the desorption (or absorption) of
lysolipid from the membrane is required for the permeability
enhancement in a sample that already contains lysolipid in the
gel phase membranes, and then is simply heated to the
transition where enhanced permeability occurs.
Results from the Thin Layer Chromatography and Nuclear
Magnetic Resonance analyses of the dialyzed samples of
DPPC:MPPC(10%):DSPE-PEG(4%) also suggested that lyso-
lipid was not desorbing out of the membrane into the external
dialysate, even after the second change of dialysate and orders of
magnitude dilution into what would be nanomolar concentra-
tions (data not shown). TLC analysis of the solution remaining
inside the dialysis bag revealed three clearly visible spots
corresponding to DPPC, DSPE-PEG andMPPC. Only two spots
were noted in the DPPC:DSPE-PEG(4%) sample, demonstrat-
ing that the MPPC signal was not simply due to hydrolysis of
DPPC to MPPC during the dialysis procedure, and that it was
retained in the liposome sample. The TLC and iodine spot
method can detect lipid amounts on the order of 0.1 Ag [46]. The
amount of MPPC in the dialyzed samples (assuming no
desorption) would be on the order of 7 Ag, well above the limit
of detection. The results from the NMR analysis of the dialysate
solution (i.e., solution outside the dialysis bag) did not reveal any
prominent peaks below 3.4 ppm that would correspond to
protons associated with lipid. The limit of detection of proton
NMR is on the order of a few tenths of a milligram of compound
[47]. If all of the lysolipid had desorbed, it would be well within
this limit (¨1 mg), but certainly, this method cannot detect
smaller fractions of lysolipid that may have desorbed. While it
appears that large amounts of MPPC are not desorbing from the
lipid membranes into the dialysate, even at temperatures above
Tm, an absolute and calibrated quantitative measurement is not
available at this time.
3.2. Activation energy determination
The temperature dependence of the ion permeability rate
constants can be expressed in terms of the Arrhenius equation
as:
Permeability Rate Constant ¼ ATexp  Ea=RTð Þ ð5Þ
Where A is a pre-exponential constant and Ea is the energy of
activation for the permeation. This relationship assumes that
both A and Ea are independent of temperature. The activation
energy for the ion permeability can be calculated by taking the
natural log of Eq. (5):
ln Permeability Rate constantð Þ ¼ lnA Ea=RT ð6Þ
A plot then of the natural log of the Permeability rate constants
vs. 1/T (absolute temperature in K) is linear with an intercept
lnA and slope Ea/R, as long as the activation energy isindependent of temperature (i.e., data in the transition region
are shown by not included in any slopes). Permeability rate
constants for all of the membranes studied are plotted in Fig. 7
vs. (1/T)1000 (K1). (The data points at 52 -C were not used
when making the Arrhenius plots as not all compositions were
measured at this temperature.) The solid lines drawn on the plot
represent the slopes used to calculate the activation energies for
POPC and DPPC (the other membranes were analyzed in the
same manner). As expected, since it does not have a transition
in the temperature range studied, only the POPC data showed a
linear relationship over the entire range, since it was liquid at
all temperatures. From the slope of the POPC data, the Ea for
dithionite permeability through this liquid state membrane was
calculated to be 36.4 kCal/mol. The other membrane composi-
tions all showed a peak at their transition temperatures,
indicating a temperature dependence in the activation energy
at the phase transition as expected, and so this transition data
was eliminated from any Arrhenius analysis.
For DPPC and both LTSLs, linear fits were made of the low
temperature regions (¨3.3–3.22 (1000/K), ¨30–38 -C) and
high temperature regions (3.17–3.11 (1000/K), ¨43–48 -C) to
calculate the activation energies through the gel and liquid state
regions respectively. The activation energies for all membranes,
along with literature values for the activation energy for water,
and several ions and non-electrolytes are shown in Table 1. It
should be noted that the liquid state regions of the DPPC,
DPPC:MPPC(10%) and DPPC:MSPC(10%) membranes are
not pure ‘‘liquid’’ phase regions as the membranes most likely
still contain interfacial regions that have not completely melted.
3.3. Doxorubicin release
A recent paper by Ickenstein et al. shows that repeated
cycling through the main acyl melting transition temperature)
/
Table 1
Activation Energies for the gel and liquid phase regions computed from
dithionite ion permeability measurements
Liposome composition Activation energy
(kCal/mol)
Gel phase region Liquid phase region
POPC:PEG(4%) N/A 36.4
DPPC:PEG(4%) 127.9 36.34
DPPC:MPPC(10%):PEG(4%) 103.7 11.74
DPPC:MSPC(10%):PEG(4%) 102.9 11.37
Solute Activation energy (kCal/mol)
through liquid membrane
H+ 18.4 [53]
K+ 15.1 [53]
Cl 17.9 [53]
Na+ 23 [1]
O2
 11.5 [54]
Glucose 25.7 [53]
Fructose 21.5 [53]
Glycerol 11 [55]
H20 9.8 [52]
Urea 9.3 [55]
Lower table shows activation energies from the literature for various solutes
through liquid phase vesicles.
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stabilized disc particles (disk-like micelles) [12]. Interestingly
then, this cycling appears to disrupt the soccer-ball morphology
of the micrograins structure of these 100 nm scale liposomes—
grain structures that we have previously seen in DMPC Giant
Unilamellar Vesicles using micropipette manipulation (Need-
ham and Evans, unpublished results), DSPC monolayers on gas
bubbles [10] and in the drug containing liposome samples
themselves by TEM [12]. In order to check for disk formation,
and rule out this potential drug releasing mechanism for our
single-cycle heating protocol, the particle size results from a
Photon Correlation Spectroscopy analysis of an extrudedFig. 8. Moles of Doxorubicin released versus time in minutes from DPPC:MSPC(10
release of 3.86 e9 moles of drug corresponds to 100% release of contents. All data
release at temperatures above the transition temperature.DPPC:MPPC(10%):DSPE-PEG(4%)Doxorubicin-loaded sam-
ple indicated a mean diameter of 120.7T27.7 nm. To
determine whether the LTSL changed size or converted to
disc-like micelles following a single heating through the
transition temperature, size measurements at a scattering
angle of 90- were made on the same sample after heating to
40.5 -C and maintaining this temperature for 30 min. The
mean size before and after heating remained virtually
identical at ¨120–122 nm, indicating that disc formation
did not occur under the conditions of our one scan heating
test, as would be experienced in use in clinical applications.
Permeability results then were solely due to membrane
transport and not vesicle disruption into membrane disc
fragments. Although an interesting observation in and of
itself, since it shows how lysolipid can possibly stabilize gel
phase bilayer edges when micrograin boundaries create the
disc templates, and points to lysolipid pores at such
boundaries as a possible precursor to full micellization, it
appears that disc formation due to stabilization of membrane
fragments requires many multiple cycles of heating and
cooling through the transition region.
To further support the conclusion that the LTSL vesicles
remain as intact bilayer membranes even after heating to Tm,
direct microscopic observations were made of large (20–30
Am) vesicles, before, during and after heating through the main
phase transition using the micropipette manipulation methods
described above. This temperature cycling was repeated four
times on the same vesicle demonstrating that the vesicles
remain intact throughout the phase transition, even though the
membranes contain lysolipid. These in situ observations of a
vesicle cycling through the phase transition again indicate that
the mechanism of drug release is not due to break up or disc-
micellization of the bilayer membrane.
A representative set of data from the doxorubicin release
measurements is shown in Fig. 8 as moles of DOX released%):DSPE-PEG(2000) (4%) vesicles at 30, 37, 39, 40, 41.3, 42 and 45 -C. The
points represent the mean of three separate experiments. Open circles represent
Fig. 10. Doxorubicin release rates (Moles/second) for DPPC:DSPE-PEG(2000
(4%), DPPC:MPPC(10%):DSPE-PEG(2000) (4%) and DPPC:MSPC(10%)
DSPE-PEG(2000) (4%), versus temperature. Lines connecting the data are
presented simply to aid the eye.
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tion demonstrates that, as a result of its slightly higher Tm, the
formulation is fairly stable up to 39 -C, releasing only 10–15%
over the course of 30 min at these temperatures. Drug release
rapidly increases when the liposomes are heated to ¨40 -C,
with 80–100% of encapsulated contents released within 20–40
s at 41.3 -C (Tm). At 42 and 45 -C, biphasic release curves are
noted, where initial release is very rapid as the liposomes pass
through the transition region, but then slows when the vesicles
completely melt and reach the desired measurement tempera-
ture above 41.3 -C.
To calculate release rates at each temperature for each
composition, the method represented in Fig. 9 was used. Moles
of DOX released (open circles) are plotted on the left hand Y-
axis versus Time in seconds on the X-axis. Plotted on the right
hand Y-axis is the temperature of the sample (corresponds to
solid line) demonstrating the rate of heating as the samples
were transferred from room temperature into the circulating
water bath, equilibrated to 40 -C for this trial. Once the sample
temperature reached 40 -C (¨40–60 s), a curve fit was used to
determine the initial rate of release of the linear portion of the
data as demonstrated by the short-dash line. The slope of this
line, m1, is the rate of DOX released in Moles/second when the
sample reached the measuring temperature of 40 -C. A linear
fit was used as this was found to best represent the initial rate of
rapid release that was noted in formulations at or near the phase
transition.
Fig. 10 shows the calculated DOX release rates (moles/
second) versus temperature for DPPC:DSPE-PEG(2000) (4%)
liposomes, and the DPPC:MPPC(10%):DSPE-PEG(2000)
(4%) and DPPC:MSPC(10%):DSPE-PEG(2000) (4%) temper-
ature-sensitive formulations. For DPPC, a slight peak in the
DOX release rate is noted at Tm (42 -C) which is ¨5 times
greater than the release rate at 37 -C, demonstrating, however,Fig. 9. Method used to obtain Doxorubicin release rates in moles/second. Moles
of Doxorubicin released from DPPC:MPPC(10%):PEG(4%) vesicles are
plotted (open circles) versus time in seconds. Along the right hand Y-axis,
the sample of the temperature is plotted as it is raised from room temperature to
40 -C (corresponds to solid line). The long dash, vertical line indicates the time
at which the sample reaches 40 -C, approximately 40–60 s. The initial linear
portion of the release curve was then fit (i.e., once the sample reached the
measuring temperature of 40 -C), with a straight line as indicated (short dash
line). The constant, m1, is the release rate in moles/second.)
:only a modest rate enhancement at the transition temperature
above the relatively impermeable solid phase. Release rates for
the DPPC:MPPC formulation begin to increase substantially
near 38 -C, reaching an apparent maximum at 40 -C that is
¨650 times greater than its relatively impermeable gel phase
and nearly 25 times above pure DPPC at the same temperature.
Rates above 40 -C could not be determined as 100% release of
all contents occurred rapidly, before the liquid phase tempera-
tures were ever reached. Release rates from the DPPC:MSPC
formulation were similar to DPPC through ¨37 -C and then
rose considerably near ¨39 -C. At the phase transition, the
release rate was 55 times greater than through its gel phase
membranes at the clinically relevant 37 -C, and ¨20 times
greater than pure DPPC at the same temperature (41.3 -C). At
temperatures greater than Tm, the rates dropped back down in
the liquid phase region, just slightly higher than for the pure
DPPC liquid phase.
4. Discussion
The addition of single chain lysolipids to pure DPPC
bilayers has produced a dramatic enhancement in the main
phase transition permeability of the membranes for permeabil-
ity markers such as carboxyfluorescein and dithionite, and for
the chemotherapeutic drug Doxorubicin as shown here. Based
on the data presented above, it appears that this enhancement is
due to permeation through transmembrane lysolipid-stabilized
porous structures initiated at the grain boundaries in a melting
membrane in the gel to liquid crystalline phase transition
region. This effect enhances the already recognized packing
mismatches that seem responsible for the anomalous perme-
ability for pure lipid melting transitions [2]. Together, with
discussion of the data, the following discussion will present
several arguments that support this conclusion.
4.1. Enhancement of dithionite permeability
Taking non-lysolipid containing membranes first, a com-
parison of the ion permeability rate constants in Fig. 4 of the
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at the same temperatures show that the DPPC permeability rate
constants to the ionic species of dithionite are ¨20-fold below
those of the liquid phase POPC, and have an activation energy
difference of a factor of about 4 (Table 1). This difference
demonstrates the relative impermeability to ions of the
condensed, solid phase lipid compared to a liquid phase
membrane at the same temperature. As melting initiates at pre-
existing DPPC grain boundaries (>39 -C), the permeability rate
constants increase as liquid regions form, resulting in leaky
interfaces between solid domains and melting liquid regions
[2]. At the transition temperature (42 -C), the area of these
highly disordered interfacial regions attains a maximum value,
accounting for the ion permeability rate constant enhancement
above that for pure liquid phase POPC at the same temperature.
While the ion permeability rate constant at the transition
temperature is nearly 130 times faster than through gel phase
DPPC (35 -C), it is important to note that this enhancement is
relatively small, only ¨1.5 times above liquid POPC at the
same temperature. In the liquid phase (DPPC > 42.5 -C), both
membranes exhibit virtually the same inherent permeability to
the ion, eventually (at temperatures only 2–3 degrees C above
Tm) reaching rates higher than those measured during the phase
transition anomaly at Tm.
Examining the transition itself, a correlation can be made
between permeability and membrane compressibility. In
transition regions for a range of lipid compositions, membrane
permeability and, especially, water permeability have previ-
ously been shown to directly correlate to membrane compress-
ibility, expressed as compliance [48]. Evans and Kwok have
also shown that the area expansion modulus of membranes
does in fact decrease in the transition region for a giant lipid
vesicle. For example, the modulus of dimyristoylphosphati-
dylcholine (DMPC) liquid phase (a diC14 chain lipid, Tm=24
-C) is ¨125 mN/m [5], while DMPC solid phase is ¨850 mN/
m [34], nearly 7 times as cohesive. But, at the phase transition
temperature, the vesicle membranes have an area expansion
modulus of only ¨20–30 mN/m [5], demonstrating the highly
compressible nature of the bilayer in this region. Theoretically
the area expansion modulus goes to zero at a first order
transition, i.e., the membrane becomes infinitely compressible.
But in reality, the lipid transition is pseudo first order [2], and
the elastic modulus approaches low (but non-zero) values,
possibly due to even slight impurities in the bilayers [5]. And,
since in general, for all membrane compositions measured to
date, the more compressible the membrane, the more perme-
able the bilayer is to water and other small molecules, we might
expect, from mechanical (continuum) arguments, that the
permeability characteristics through the transition region would
also be directly related to the elastic area expansion modulus
(Ka) of the membranes and so increase dramatically at the
transition, which it does. For DPPC, permeability through the
dense, solid phase was, as expected, substantially lower than
through the more compressible, liquid phase. The surprising
result, in the light of recent modeling [2,8] and earlier
experiments [1], was that the ion permeability, at the extremely
compressible phase transition region, was only 1.5 timesgreater than through a similar liquid phase lipid at the same
temperature (and appears to involve the melting and chain
mismatch at these melting boundaries for DPPC, that are
obviously absent from a purely liquid bilayer like POPC at 42
-C [49]).
In contrast, measurements of the lysolipid temperature-
sensitive liposomes demonstrate a dramatic permeability
enhancement at the phase transition due to the presence of
lysolipid in their bilayer prior to heating through Tm.
Permeability rates through the DPPC:MPPC(10%) gel phase
vesicle membranes (<37 -C), are nearly identical to the pure
gel phase DPPC vesicles, and are stable up to body temperature
(37 -C). One of the most important pieces of data from this
study is shown in Fig. 5 where a significant increase in
permeability starts at the shoulder of the DSC trace (¨39 -C),
before any significant melting of the LTSL membranes,
implying a role for melted grain boundaries. DPPC:MPPC
permeability rates at 39 -C are nearly 20-fold above gel phase
DPPC and approximately 5 times higher than the liquid phase
POPC at the same temperature. The postulated lysolipid-
stabilized pores enhance the ion permeability through the
membrane far above not only what was measured through a gel
phase/melting DPPC bilayer, but also through a pure liquid
POPC vesicle. The rate enhancement reaches a peak at the
transition temperature of the LTSL (¨40.5 -C), that is nearly
20-fold higher than DPPC at the same temperature, and ¨650-
fold higher compared to permeability through the gel state (35
-C). After the bilayers melt (>40.5 -C), the permeability drops
below the peak maximum as the interfacial area (between
remaining solid and melted domains) starts to reduce, but
remains ¨2–3 higher than liquid state DPPC or POPC
membranes, indicating the continued role of possible lysolipid
stabilized defects in persistent microstructure (see later in
Discussion).
The DPPC:MSPC(10%) formulation also exhibits low ion
permeability rates in the gel phase, similar to pure DPPC. The
addition of the longer chain C18 lysolipid not only raises the
transition temperature relative to the DPPC:MPPC formulation
by 0.7 -C, but also slightly increases the temperature at which
significant ion permeability initiates from ¨38 -C to 39 -C,
which may be important in the clinical use of the formulation
where the liposome has to be stable and not release drug at 37
-C, but can be triggered to release above body temperature, but
not too high that it can’t be reached by mild hyperthermia. As
with pure DPPC and the MPPC formulation, the peak in
permeability coincides with the peak in the transition as shown
in Fig. 5. The ion permeability rates through the MSPC
containing membranes at the transition temperature are more
than 600 times faster than through the gel phase membranes,
and nearly 10 times as fast as DPPC at the same temperature
(41.3 -C).
To reiterate now for all membrane systems, the most telling
characteristic regarding mechanism of permeability, is that
permeability begins to increase significantly prior to any
significant melting of lipid registering on a calorimetric scan
(Fig. 5). In all cases, the enhancement initiates before any
significant shoulder of the DSC trace. Examining the rates as a
J.K. Mills, D. Needham / Biochimica et Biophysica Acta 1716 (2005) 77–9690function of relative temperature, T/Tm, provides a comparison
of the point at which permeability begins to increase for each
membrane (plot not shown). Enhanced permeability through all
membranes begins at nearly the same relative temperature
(¨0.992), with the DPPC:MPPC formulation initiating at
perhaps a slightly lower relative temperature than the other
two membranes (¨0.990).
Mouritsen’s dynamic models of the phase transition region
indicate that, in DPPC membranes, interfacial areas between
the solid phase membrane and newly melted regions begin to
form, starting at the intergrain boundaries just above 37–38 -C
[2,13]. Based on this, his model of the relative permeability
indicates that significant enhancement begins at a relative
temperature near 0.99 for DPPC vesicles, and this is confirmed
by our results. Mouritsen’s models also suggest, surprisingly,
significant interfacial regions exist far beyond Tm, out to near
47–48 -C for DPPC [13]. If this were true in real membranes,
then, at these interfacial regions, for membranes that contain
lysolipid, lysolipid stabilized pores could still exist, accounting
for the moderate enhancement noted in the liquid phase LTSLs
that still existed at values above those of liquid DPPC and
POPC membranes. At higher temperatures (data at 52 -C in
Fig. 4), it is expected that no interfacial regions remain, and the
permeability rate constants through the liquid state DPPC and
liquid state DPPC:MSPC(10%) are at virtually the same level.
The slight enhancement still noted with the MSPC is most
likely due to the presence of the single chain second
component lipid, as supported by POPC:MPPC data presented
later which also shows a slightly enhanced permeability. A
more detailed description of the enhancement mechanism is
provided below.
In the Arrhenius plots (Fig. 7), DPPC and both LTSLs
showed a peak at their transition temperature, indicating the
expected temperature dependence in the activation energy at
the phase transition. This peak due to the presence of liquid–
solid interface region contrasts the discontinuity noted in other
two-phase systems [50,51].
In the Arrhenius plots (Fig. 7), the activation energy through
POPC and liquid state region DPPC was determined to be ¨36
kCal/mol. As expected, values for the three gel state membranes
demonstrated a much greater barrier to the ion permeability. For
DPPC membranes, Ea was ¨128 kCal/mol, nearly 4 times that
of the same membrane in its liquid state. For both of the
lysolipid membranes, the energy barrier is similar but slightly
lower than this pure lipid value at ¨103 kCal/mol. While the
energy barrier to permeability for both liquid phase DPPC and
POPC was nearly identical at 36 kCal/mol, a significant drop is
noted for both liquid phase LTSLs to¨11 kCal/mol, in line with
them being much more permeable in the liquid phase region,
where the lysolipid introduces a chain vacancy defect per
molecule (as well as the presence of interfacial regions that still
remain), in a temperature range just above Tm.
For comparison, Ea for water permeability through the
liquid phase membranes of SOPC (C18:0–C18:1, Tm=¨6 -C)
has been measured at room temperature to be approximately
9.8 kcal/mol [52] and Ea for Na
+ permeability through DOPG
membranes (Tm=18 -C [23]) was determined to be ¨23kcal/mol [1]. The activation energy for dithionite ion perme-
ability through a liquid phase membrane would be expected to
be a fair amount higher than the activation energy associated
with water permeability due to the negative charge of the ion,
and be slightly greater than the energy required to transport the
smaller sodium ion, radius ¨1.9 A˚ vs. 3 A˚ for SO2
, through a
liquid membrane. The results for liquid phase DPPC and POPC
then seem to be reasonable.
The activation energies for the liquid phase region LTSLs
are quite low, at or below those measured for water and several
non-electrolytes that transport presumably through homoge-
neous lipid membranes (see Table 1) [53–55], and so represent
additional evidence that ion transport is through a more
aqueous pore than through the lipid per se in this transition
region. Above Tm, as noted above, interfacial regions are
hypothesized to persist at temperatures up to ¨48 -C in the
LTSL membranes. The energy barrier here may be associated
with both permeation through the pure liquid state of the
bilayer, containing the 10 mol% chain vacancy defects, and a
characteristic of lysolipid pores still present at the few but
remaining interfacial regions that facilitate ion transport,
providing some experimental evidence for their existence
above the transition region as postulated by Mouritsen et al.
[2].
4.2. Enhancement of doxorubicin release
Concerns about constant excitation bleaching the fluores-
cent signal from DOX dictated that the drug release experi-
ments were performed on individual samples as outlined in
Materials and methods. As a consequence, for release experi-
ments conducted at temperatures above Tm, every sample was
heated (quickly) through the transition on its way to the desired
liquid state temperature. Only after the sample reached the
desired temperature could accurate rates be calculated (as
demonstrated in Fig. 9) since the initial jump in release was due
to permeability through the transition region.
For the DPPC:MPPC formulation, accurate permeability
rates could only be calculated up to the transition region, near
40 -C. Measurements for liquid state vesicles could not be
made, since by the time the membranes reached the temper-
ature of interest (taking ¨40–60 s), 100% of the drug had
already been released as they passed through Tm. (This release
is certainly a desired effect for performance in any clinical
application for drug delivery to the tumor, but compromises to
some extent these studies concerning characterization of drug
release in vitro.) In the case of the DPPC:MSPC formulation
(Fig. 8), a biphasic release curve is noted for temperatures
above Tm. The initial 20–40 s of release for 41.3 -C and 42–
48 -C was nearly identical as the membranes passed through
the transition region. As they were heated above the region
(again taking 40–60 s), a measurement of the release rate
through the liquid state membrane could then be made, with the
remaining doxorubicin leaking out, showing that release rates
did slow down above Tm.
The data in Fig. 10 demonstrate a dramatic 20-fold
enhancement in the Doxorubicin release rates of the DPPC:
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loaded, the DOX in the liposomes is complexed and
crystallized at low pH and is not permeable through the
membrane. Only a tiny fraction of drug (less than 0.01%) is
expected to be non-protonated at this pH of 4. It is unlikely
then that drug is leaking out of the vesicles in this region via a
simple lipid membrane solubility mechanism (even though the
lipid melts, the membrane is still intact and represents largely,
over most of its area, a hydrophobic low dielectric constant
barrier to ion flow). In their transition region though, the
presence of grain boundaries and the possibility of lysolipid
pores and the rapid release of drug suggest that the entire
contents of the liposome, both the hydrophobic unprotonated
DOX and the larger fraction of membrane non-permeable
DOXH+, as well as the citrate buffer and dissipation of the pH
gradient, are crossing the bilayer. As noted in the dithionite
permeability data, drug permeability enhancement starts almost
2 -C before the midpoint of the main calorimetric transition,
adding additional support to the permeability enhancement of
leaky membrane interfacial regions near 38 -C. Measurements
of the liquid phase DPPC:MSPC vesicles indicate that the
release rates drop back to levels just slightly above those for the
DPPC bilayers. Since approximately 50% of the encapsulated
drug leaked out of the vesicles as they were heated through the
transition, the pH gradient across the bilayer most likely
diminished as well. Therefore, the measured values may not
necessarily reflect the true release rates for a liquid state
membrane if it could be made to start at this temperature with
the same internal amount of drug and concentration gradient
starting condition. Ideally, the release rates above the transition
could be measured on a single sample, heated much more
rapidly so as to limit release of drug and H+ ions in the
transition region, but we did not achieve this in the present
study.
Although experimental factors limited the ability to measure
the true Doxorubicin release rates above the transition
temperature, the results presented here provide important and
clinically relevant data. In clinical treatment scenarios, lipo-
somes could be introduced intravenously to the patient after
heating the tumor to the desired temperature of a mild
hyperthermia treatment, around 40–42 -C. The liposomes
would be elevated from body temperature (37 -C) to the
hyperthermic temperature in the heated tumor region, even in
the blood stream of the tumor, at a rate comparable to the
experiments performed here. Based upon these experiments, if
liposomes, as they flow through the tumor vasculature, are
exposed to temperatures in the range of ¨40–42 -C for as little
as 40–60 s, significant amounts of drug (80–100%) would be
released from each liposome passing through the heated region.
Of course, sustained and continued heating would allow greater
numbers of liposomes to pass through and release their
contents in the blood stream. Since transit times through
tumors are on the order of only a few microns per second,
release time matches or is less than transit time of the blood
borne liposomes through the tumor and so drug release is
immediate, and if in the blood stream, would also possibly
affect the endothelial cells as well. This represents a newparadigm for local drug delivery. Rather than designing for,
and relying on serendipitous liposome extravasation into tumor
tissue, the application of mild hyperthermia producing trig-
gered drug release in the blood stream, allows for diffusion into
both endothelia and tumor tissue and adds an additional
advantage in therapy. Of importance to clinical application is
our in vitro result that, if the final temperature obtained is much
above 42 -C, and if the rate of heating of the liposomes as they
pass into the heated tumor region is such that the membranes
do not spend sufficient time in their transition region, the rate
of release could diminish significantly at these (even slightly)
higher temperatures and a much smaller amount of drug would
be supplied to the tumor than if the temperature was maintained
at just below or at the phase transition midpoint temperature of
41.3 -C. The composition and material state of this liposome
membrane undergoes a very sharp and critical transition and
drug release mechanism, and has been designed to be so. It is
probably unlikely that the heating rates in vivo (normally about
1 -C/min—personal communication R. McGough, Department
of Radiation Oncology, Duke University Medical Center)
would approach those used in these experiments (¨15 -C/
min), so this may not be a concern, and all drug is expected to
be released from the liposomes as they attain hyperthermic
temperatures in the 40–42 -C range, even in the blood stream,
possibly, as mentioned, obviating a necessity to allow time for
and require extravasation into tumor tissue [11]. With respect to
action on endothelial cells of the tumor blood vessels, what we
have seen is that before treatment, the red blood cell (RBC)
velocity in tumors was 0.428T0.037 mm/s and the microvas-
cular density was 3.93T0.44 mm/mm2. At 24 h after the
treatment, they were reduced to 0.003T0.003 mm/s and
0.86T0.27 mm/mm2, respectively. The same treatment, how-
ever, caused only a 32% decrease in the RBC velocity and no
apparent change in microvascular networks in normal subcu-
taneous tissues over the same period. And so, the rapid release
of DOX during hyperthermia allows the drug to shutdown
tumor blood flow while having only minor effects on normal
microcirculation in subcutaneous tissues [66]. In some tumors,
few functioning blood vessels are left remaining in the tumor,
and the blood flow is essentially zero. The formulation and
rapid mode of delivery and location of drug release then look to
be able to provide an anti-vascular as well as anti-cancer cell
mechanism of anti-tumor therapy.
The permeability data presented here clearly demonstrate
the dramatic enhancement in both ion permeability and drug
release rates that the incorporation of lysolipid creates above
single component lipid membrane systems. It is interesting
then to make a comparison between the release rates for the
two molecules by examining the permeability coefficients at
the transition temperatures of the pure DPPC and the
DPPC:MSPC(10%) liposome systems (the permeability coef-
ficients for DPPC:MPPC(10%) were not calculated since
DOX data was not available at the transition temperature).
The data from the dithionite permeability measurements
were curve fit using Eq. (4) above, which can be represented as:
C tð Þ ¼ C0exp m2Ttð Þ ð7Þ
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concentration of un-reacted NBD molecules at time t, and Co
is the concentration of un-reacted NBD molecules on the inner
monolayer at time zero (i.e., when the dithionite was added).
For dithionite ion permeability, the number of dithionite ions
added to the cuvette outnumbered the NDB molecules by
1000:1, and it was assumed that once an NBD molecule reacts,
it does not dissociate from the bound state (supported by
experiments measuring NBD-lipid flip-flop that last hours to
days [56]). The measured rate, m2 from Eq. (7), can be
expressed in terms of the permeability coefficient [65] as
m2 ¼ S1P=V1 ð8Þ
Solving for the permeability coefficient, P and reducing the
equation yields
P ¼ m2TV1=S1 ¼ m2TR=3 ð9Þ
Where R is the radius of the liposomes, ¨60 nm. Based on this
assumption, the Dithionite ion permeability coefficient for pure
DPPC:DSPE-PEG(4%) at 42 -C and DPPC:MSPC(10%):
DSPE-PEG(4%) at 41.3 -C can be calculated.
PSO2 for DPPC : DSPE  PEG 4%ð Þ ¼ 1:9*109cm=s
PSO2 for DPPC : MSPC 10%ð Þ : DSPE PEG 4 %ð Þ
¼ 1:09T108cm=s
—a factor of five, then, for SO2
.
The release of doxorubicin from the membranes can be
expressed as
dC=dt ¼  S1P=V1TC ð10Þ
where dC/dt is the change in concentration of the doxorubicin,
Sl is the surface area of the liposomes, P is the permeability
coefficient, Vl is the volume of the liposomes, and C is the
initial concentration of the doxorubicin inside the liposomes.
From the Doxorubicin release measurements, the perme-
ability coefficients can be calculated using Eq. (10), where the
measured initial release rate in moles/second is dC/dt, the total
encapsulating volume of the liposomes (Vl) in the test tubes
was 61.8 nL, the total surface area of the vesicles through
which the drug was permeating (Sl) was 119 cm
2, and the initial
amount of drug inside of the vesicles (C) was 3.86109 mol.
The permeability coefficients for DOX are then
PDOX for DPPC : DSPE PEG 4%ð Þ ¼ 3:4T1010cm=s
PDOX for DPPC : MSPC 10%ð Þ : DSPE  PEG 4%ð Þ
¼ 3:3T109cm=s
—a factor of ten for DOX.
Thus, the permeability coefficients at the transition temper-
ature for both ion and drug are higher for the lysolipid
containing membranes compared to the pure DPPC mem-
branes, as expected from the release rates, by about an order of
magnitude. Comparing the ion and DOX permeability, for the
pure DPPC membranes, the permeability coefficient for thedithionite ion (radius ¨3 A˚) is about six times larger than the
coefficient for the DOX molecule (radius ¨500 A˚), demon-
strating that the smaller ion can permeate the bilayer more
easily. For the DPPC:MSPC(10%) membranes, the permeabil-
ity coefficient for dithionite is only about three times higher
than the permeability coefficient for DOX through the same
membrane. Since the permeability barrier is believed to be a
water-filled pore (see below) rather than the hydrocarbon chain
region, the larger size of the doxorubicin molecule plays less of
a role in reducing the permeability coefficient through the
lysolipid containing membrane than it does through the pure
lipid membrane that presumably has less or no stabilized pores,
relying more on solid/liquid acyl chain mismatches.
4.3. Proposed mechanism of permeability
enhancement-lysolipid-stabilized pores
Detergents have been recognized since the late 1970s to
cause membrane-spanning pores in liquid phase bilayers [57],
and have been shown to increase phase transition permeability
when subsequently added to pre-formed liquid-phase liposome
suspensions [58]. Based on our dialysis experiments (where
lysolipid, already in the liposome membranes, was found to
remain in the membranes even upon extensive dialysis
preserving the temperature-triggered permeability) and experi-
ments where MPPC was incubated with preformed DPPC
vesicles to produce the same results, it is our conclusion that
lysolipid is an absolute requirement for the kind of high rates of
solute permeation enhancement we have observed. It is though,
the presence of lysolipid in both halves of the membrane,
already present in solid solution prior to thermal processing,
that distinguishes the LTSL mechanism for in vivo application
from other thermal-sensitive liposome compositions and their
performance. From TLC and NMR analysis, it also appears that
very little, if any, lysolipid leaves the membranes in the liquid
phase by wash-out, indicating that the enhancement mecha-
nism does not seem to be due to desorbing lysolipid ‘‘leaving
vacancy defects,’’ as we might have originally thought. Based
on the data presented in this paper, it now appears that the
presence of lysolipid enhances the permeability of DPPC
vesicles at the phase transition, presumably by stabilizing pores
at melting grain boundary regions, even though equilibrating
lysolipid is not present in the bathing medium. With this
circumstantial evidence in hand, we now postulate mechanisms
of permeability for each of the three regions, gel phase,
transition and liquid phase regions.
4.3.1. In the gel phase
For the gel phase bilayers, ion permeability rates through
both LTSL membranes were extremely low and virtually
identical to those through the solid DPPC membranes. A slight
difference in the activation energies between the two (¨128
kCal/mol for DPPC vs. ¨103 kCal/mol for LTSLs) may be a
result of lysolipid being uniformly distributed throughout the
solid bilayers. The mechanism of ion permeability through
synthetic lipid bilayer membranes is still not fully understood.
Several reports support the conclusion that ion permeability
J.K. Mills, D. Needham / Biochimica et Biophysica Acta 1716 (2005) 77–96 93through the bilayer occurs by a solubility–diffusion mecha-
nism [49,59], where the ion must first partition in the
membrane, then diffuse across the bilayer midplane, and
finally partition into the internal aqueous phase [59]. This is
the primary mechanism believed to account for water and non-
electrolyte permeability [49]. Others believe that permeability
occurs through short-lived, hydrated transient pores produced
during thermal fluctuations [3,60]. Here, the permeating
molecule avoids the energy barrier associated with the
hydrophobic interior of the membrane.
In the gel phase region, solubility-diffusion into the lipid
bilayer is most likely the dominant mechanism, since thermal
fluctuations should be fairly small (in this highly condensed,
high modulus membrane [34]). As hydrated ions approach the
surface, they pass through the membrane by first partitioning,
and then dissolving through the membrane. For gel phase
lysolipid membranes, the single chain PCs pack normally at the
interface (same head group) [61], but allow additional free
volume in the hydrocarbon region due to their single chain per
molecule and concomitant chain vacancy defect [18]. These
packing or chain vacancy defects (at about 10 mol%) could
facilitate transmembrane transport and lower the activation
energy barrier for ion diffusion through the bilayer, especially
at grain boundaries, even prior to melting, due to mismatches
in packing at these crystalline structure-defects.
4.3.2. In the transition region
As the membranes begin to melt, liquid–solid interfacial
regions form at existing grain boundaries. Although calorimet-
ric changes (increase in endothermic heat flow) are not
measurable until near 40–41 -C for DPPC (proportional to
the mass of lipid melted), significant interfacial (solid/liquid)
area is predicted to start to form near 38 -C, about 4 -C below
the main transition temperature [13]. Similarly, fluorescence
spectroscopy data from dimyristoylPC (DMPC, C14) vesicles
indicate the formation of interfacial regions at ¨20 -C, which
is also 4 -C below the main transition for this lipid [62] as
predicted by cooperative transition models [7]. These highly
disordered interfacial areas account for the increase in
permeability, and therefore an increase in their area directly
corresponds to an increase in the ion permeability [2].
For the LTSL membranes, increases in the interfacial area
start at slightly lower absolute temperatures, since Tm is ¨1 -C
lower than for the pure lipid DPPC membranes (the lysolipid
slightly liquefies the membrane and the transition temperature
is lowered by about a degree for inclusion of 10 mol% MPPC
and 0.5 -C for inclusion of 10 mol% MSPC compared to the
pure DPPC membrane). As soon as these grain boundary
regions liquefy, lysolipid has the opportunity to form defect
structures that stabilize pores along the highly compressible
liquid–solid boundaries. As a result of their conical molecular
shape (large head group, single chain) [63], and tendency to
form spherical micelles in aqueous solution, these lysolipid
molecules are well suited to form headgroup lined pores. Ions
no longer have to interact with the low dielectric, hydrophobic
region of the membrane, but can now pass through a headgroup
lined, aqueous pore. Consequently, the permeability rates aredramatically higher than those of DPPC throughout the
transition region, and about 6 times higher at the relative
transition (T/Tm=1). The permeability rates through the MPPC
formulation are ¨1.1 times greater than through the MSPC
formulation at T/Tm=1. Although both LTSL membranes
should contain about the same amount of interfacial area, it
appears that either the monopalmitoyl lysolipid forms more of
the porous structures, or the pores that it forms are more stable,
resulting in the slightly higher rate of ion permeability. This
difference is not surprising since its shorter aliphatic chain
(C16 for MPPC vs. C18 for MSPC) gives it a slightly more
conical geometry, which should allow it to pack more easily
into the hemispherical shape required in the pore [63] and
match the hydrophobic thickness of the DPPC membrane.
4.3.3. In the liquid phase
Data for the LTSL membranes demonstrate an enhanced
permeability above liquid DPPC from above Tm to ¨48 -C.
These results support two conclusions. (1) Lysolipid is still
present in the membranes, and has not desorbed from the 100-
nm vesicles. (2) Coupled with this, the continued enhancement
is a result of the presence of solid/liquid interfacial regions and
lysolipid-stabilized pores that persist up to ¨48 -C. The models
from Mouritsen suggest that interfacial regions exist out to 47–
48 -C for DPPC liposomes, 5–6 -C above the mid point
transition temperature [13]. Fluorescence spectroscopy data
from DMPC vesicles also confirm the presence of grain
interfaces 3–4 -C beyond the transition temperature in support
of Mouritsen’s model [62]. In addition, membrane thermal
expansivity does not reduce to its steady state liquid phase value
until a few degrees above the transition temperature of DMPC
indicating the continued presence of some high compressibility,
solid–liquid interfaces [34]. At temperatures above 48 -C,
theory predicts that no interfacial areas remain, and the two
membrane permeabilities (DPPC and DPPC:MSPC at 52 -C)
coincide, with the minor enhancement from the presence of
lysolipid over pure DPPC at 52 -C probably a result of
increased free volume in the membrane, similarly noted for gel
phase LTSLs.
Additional support for the presence of interfacial regions
and lysolipid pores is presented in Fig. 11. Dithionite ion
permeability rates are shown for DPPC, POPC, DPPC:
MPPC(10%) and an additional system, POPC:MPPC(10%)
where 10% MPPC was incorporated in this membrane during
hydration, just as with the LTSLs. Lysolipid in the POPC liquid
phase membranes causes only a very small increase in the
permeability rates above pure POPC over the entire tempera-
ture range. Obviously, POPC membranes do not contain any
grain structure and so this is as a result of a slightly increased
free volume in the hydrocarbon region (one less chain per
molecule on same PC headgroup introducing a chain vacancy).
These measurements support the minor permeability enhance-
ment noted at 52 -C for the DPPC:MSPC formulation.
Importantly, the dithionite permeation rates through the
POPC:MPPC vesicles are substantially lower than in the
DPPC:MPPC liquid phase vesicles (42–48 -C). If the
permeability enhancement in the liquid phase was only due
Fig. 11. Comparison of the dithionite ion permeability rate constants (1/min)
through DPPC:DSPE-PEG(2000) (4%), POPC:DSPE-PEG(2000) (4%),
DPPC:MPPC(10%): DSPE-PEG(2000) (4%) and POPC:MPPC(10%):DSPE-
PEG(2000) (4%) membranes as a function of temperature.
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free volume), the permeability rates should coincide in this
region. That the permeabilities of the two different composi-
tions do not match add support to the conclusion that the
enhancement is due to the presence of residual interfacial areas
with lysolipid-stabilized pores in the DPPC-Lysolipid contain-
ing systems. The transition temperature of POPC vesicles is
 2 -C, so they do not have any interfacial regions at, what is
then, over 40 -C above this temperature for the stabilized pores
to form.
One last supporting piece of evidence for the proposed
presence of interfacial areas (and lysolipid pores) extending
into the liquid phase region of the LTSLs comes from
mechanical measurements of lysolipid containing EggPC
vesicles. Zhelev has measured the area expansion modulus
of monooleoylphosphatidylcholine (MOPC):EggPC (10–30%
lysoPC) bilayers and determined that the intrinsic area
expansion modulus of MOPC is ¨150 mN/m, almost iden-
tical to the modulus for pure EggPC (¨170 mN/m) [64].
Therefore, a linear combination of the two lipids, and moduli,
e.g., KaMixture=KaMOPC(10%)+KaEggPC(90%) would also
produce a modulus of ¨150–170 mN/m. As noted above, a
decrease in modulus (increased compressibility) relates direct-
ly to an increase in permeability. If the presence of 10%
MOPC does not significantly lower the modulus of a liquid
state bilayer, it should not significantly increase the perme-
ability (i.e., the only small enhancement noted with MPPC
in POPC), as observed, but it does play a role at the remaining
solid– liquid boundaries in the obstensibly liquid state
membrane.
From TLC and NMR analysis, very little, if any, lysolipid
appears to desorb from liquid phase membranes even when
held in dialysis at a temperature of ¨45–48 -C for 48
h (although a truly quantitative measurement is still lacking,
and it is possible that dialysis may not remove the very small
amounts of desorbed lysolipid from the vesicle suspension). At
first glance, this finding conflicts with the lysolipid absorption/
desorption data of Zhelev and Needham [21,35] where theyshowed uptake and then washout of lysolipid from liquid phase
vesicles using the flow micropipette technique. In the case of
the flow pipette experiments though, lysolipid was introduced
into large (¨20 Am), unilamellar vesicles in situ. From area
change measurements observed on these giant vesicles, initial
uptake is into the outer monolayer occurred at a rate of ¨0.2/s.
Both sides of the membranes expanded, and eventually
lysolipid flipped at a slower rate (0.002/s) to the inner
monolayer. Desorption, though (¨0.2/s), was only observed
from the outer monolayer at short times before significant lipid
was able to flip and populate the inner monolayer [21,35].
In contrast, the vesicles used in the present experiments
were 100 nm in diameter and prepared with lysolipid already in
the membrane at 10 mol% (i.e. ¨10% in each monolayer). For
lysolipid to desorb, it first must leave from the outer monolayer
at a rate 100 times faster than the transfer across the bilayer. For
this to occur, the outer monolayer must compress compared to
the inner monolayer and this would be expected to make the
membrane bend inwards to accommodate the loss of material
(area and volume) from the outer monolayer. Presumably, the
energy required for this ‘‘buckling’’ to take place is so high
relative to the chemical potential of lysolipid in solution that it
does not occur, so lysolipid remains in both sides of the
membrane and does not desorb.
It is important to note that the conical geometry of the
lysoPCs is crucial, as it allows them to form the required,
highly curved, hemispherical shape of the pore. We have also
measured dithionite permeability through DPPC membranes
that contained 10 mol% of monopalmitoyl-glycerol (GMP).
This molecule is identical to MPPC (single C16 chain, glycerol
backbone), except that it does not have the relatively bulky PC
head group. Permeability results (data not shown) indicated no
enhancement of dithionite permeability compared to pure
DPPC, indicating that presumably, GMP was not able to
stabilize porous defect structure, as MPPC was. The geometry
of the GMP molecule is more ‘‘cylindrical’’ or even inverse-
conical without the large PC headgroup, and as such, it would
not be expected to form and stabilize the highly curved sides of
the membrane pore having intrinsically the opposite curvature.
In addition, the molecule is highly hydrophobic, so it is
unlikely that it would form a water lined structure through the
membrane and certainly should not desorb. A recent paper
from Langer and Hui has measured the dithionite ion
permeability through DimyristoylPC (DMPC-diC14) vesicles
at their transition temperature (¨24 -C) with and without free
fatty acids [33]. For pure DMPC vesicles, the ions cross the
membrane rapidly, quenching all of the NBD-fluorescent
molecules within ¨2–3 min. The addition of 10 mol% stearic
acid to the membrane reduces the permeability rate by a factor
of ¨2 while the addition of the unsaturated oleic fatty acid
reduced the rate almost 10-fold. Not only does the addition of a
single fatty acid chain not enhance the permeability, but its
presence in the membrane interfacial region actually retards ion
permeability. This data again support the proposal that the
favorably conical shaped lysolipid and its ability to form head
group lined membrane pores are essential for the enhanced
permeability.
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The results from this work provide some support to the
hypothesis that the rapid release of contents from LTSL
membranes occurs through lysolipid-stabilized pores at grain
boundary regions in otherwise intact membranes at their main
acyl melting transition region. It should be noted though that
the presence of pores has not been absolutely proven by this
data. Measurements of dithionite permeability and Doxorubicin
release indicate permeability rate enhancement begins several
degrees below the peak of the thermal transition, and extends
several degrees past it. These results are in line with, and
support, the interfacial permeability models of Mouritsen that
predict the presence of interfacial solid– liquid boundary
regions both before and after the main calorimetric peak.
Although some lysolipid desorption from liquid state mem-
branes cannot be ruled out, it appears that lysolipid must
remain in the membrane for the permeability enhancement. It
should be noted that lysolipid desorption has not been
completely ruled out as a mechanism for enhanced permeabil-
ity at the phase transition. The results from both the particle
size analysis and the temperature cycling study with the
micropipette indicate that LTSLs remain as intact bilayers
during the phase transition, as well as after several cycles
through Tm. It appears the permeability enhancement mecha-
nism is lysolipid pore stabilization, and not a result of complete
destruction or micellization of the vesicles.
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